The short version of mass spectrometry fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-07-31. Anything still debated is marked as such rather than presented as settled.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
| Property | Value | Notes |
|---|---|---|
| Solid-state storage | -20 degrees Celsius or lower | Desiccated and protected from light |
| Solution stability | Short and method-dependent | Confirm by stability testing |
| Purity assessment | Reversed-phase HPLC | Reported as area percent |
| Identity confirmation | LC-MS or comparable method | Mass match against expected value |
| Common synonyms | MT-II; melanotan II | Informal and catalogue names |
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
Dantrolene sodium, sold under the brand name Dantrium among others, is a postsynaptic muscle relaxant that lessens excitation-contraction coupling in muscle cells. It achieves this by inhibiting Ca2+ ions release from sarcoplasmic reticulum stores by antagonizing ryanodine receptors. It is the primary drug used for the treatment and prevention of malignant hyperthermia, a rare, life-threatening disorder triggered by general anesthesia or drugs. It is also used in the management of neuroleptic malignant syndrome, muscle spasticity (e.g. after strokes, in paraplegia, cerebral palsy, or patients with multiple sclerosis), and poisoning by 2,4-dinitrophenol or by the related compounds dinoseb and dinoterb. The most frequently occurring side effects include drowsiness, dizziness, weakness, general malaise, fatigue, and diarrhea. It is marketed by Par Pharmaceuticals LLC as Dantrium (in North America) and by Norgine BV as Dantrium, Dantamacrin, or Dantrolen (in Europe). A hospital is recommended to keep a minimum stock of 36 dantrolene vials totaling 720 mg, sufficient for a 70-kg person.
BV(relative) = relative BV of the test protein BV(reference) = percentage BV of reference protein (typically egg: 93.7%). BV(percentage) = percentage BV of the test protein While this conversion is simple it is not strictly valid due to the differences between the experimental methods. It is, however, suitable for use as a guideline.
Metalloids are sometimes called semimetals, a practice that has been discouraged, as the term semimetal has a more common usage as a specific kind of electronic band structure of a substance. In this context, only arsenic and antimony are semimetals, and commonly recognised as metalloids.
== Adverse effects == The main adverse drug reaction associated with calcitriol therapy is hypercalcaemia – early symptoms include: nausea, vomiting, constipation, anorexia, apathy, headache, thirst, pruritus, sweating, and/or polyuria. Compared to other vitamin D compounds in clinical use (cholecalciferol, ergocalciferol), calcitriol has a higher risk of inducing hypercalcemia. However, such episodes may be shorter and easier to treat due to its relatively short half-life. High calcitriol levels may also be seen in human disease states in patients not on supplementation. In someone with hypercalcaemia and high calcitriol levels, low intact parathyroid hormone levels are usually present. The major conditions with hypercalcaemia due to elevated calcitriol levels are lymphoma, tuberculosis and sarcoidosis where excess production occurs due to ectopic 25(OH)D-1-hydroxylase (CYP27B1) expressed in macrophages. Other conditions producing similar findings including:
== Applications of LTLs in medicine == Ligand-targeted liposomes are used for a variety of applications depending on the liposome, ligand, and liposome contents. Ligand-targeted liposomes can be used for diagnostics through imaging. The liposomes can contain imaging agents to aid in visualization such as fluorescent dyes, labeling probes, and contrast agents. Commonly, a radioactive gamma-emitter, fluorescent marker, or magnetic resonance imaging (MRI) agent is encapsulated in the liposome for this application. The active targeting mechanism of LTLs allows the target tissue to retain the imaging agent while the remaining agent is cleared from circulation. The ligand-targeted liposomes increase the specificity and sensitivity of the images taken through positron emission tomography (PET), single-photon emission computed tomography (SPECT), and MRI techniques through the ligand localization to receptors of interest. Biotinylated liposomes containing [67Ga] coupled with a later injection of avidin have been shown to reduce background signal and produce the needed contrast for imaging while reducing the circulation time of radioactive imaging agent. Molecular imaging of processes over time in vivo is also made possible using ligand-targeted nanoparticles. As of 2015, many ligand-targeted imaging agents such as MIP-1404, MIP-1405, MIP-1072, MIP-109, and 18F-DCFBC were undergoing clinical trials. The ability of a liposome to encapsulate these imaging agents and deliver them to specific regions through ligand targeting is helpful for precision detection.
Sources: en.wikipedia.org
== Radiometric age and geological age == Radiometric age represents the time when the decay process starts. Geological age represents the time when a geological event occurs. Manipulating the isotopic ratios can only give us radiometric age. To obtain the geological age, we need to know the relationship between the two. In other words, how do geological events affect the radioactive system in monazite? Actually, the radioactive system is like a digital 'clock', while the geological processes can be like replacing a battery. When a new battery is inserted, this 'clock' starts counting from 00:00. This process is what we call the age resetting mechanism. In monazite, the age resetting is caused by the loss of Pb. Pb is produced continuously by the decays of U and Th since the radioactive system (clock) starts running. The more Pb (or less U and Th) the system contains means the longer period has been passed. If all Pb are suddenly removed from monazite by a geological event (replacing battery), the age become zero (00:00) again. Before thinking what exact geological events trigger Pb loss (see section: Interpretation and application), it is important to know the two mechanisms causing Pb loss in monazite.
== Sources == Ahuja, I., Dauksas, E., Remme, J. F., Richardsen, R., & Løes, A. K. (2020). Fish and fish waste-based fertilizers in organic farming - With status in Norway: A review. Waste management (New York, N.Y.), 115, 95–112. Anu Prasanna, V., Chandrasekhar, T., Riazunnisa, K., Kumar, P. R., Teja, S. V. R., Rajeswari, D., Reddy, M. C., Wee, Y.-J., & Lebaka, V. R. (2023). Fish Waste: A Potential Source of Biodiesel. Fermentation, 9(9), 861. Bekker-Nielsen T (2005) Ancient fishing and fish processing in the Black Sea region Volume 2 of Black Sea studies, Aarhus University Press, ISBN 978-87-7934-096-1. Bremner HA (2003) Safety and Quality Issues in Fish Processing Woodhead Publishing Limited, ISBN 978-1-85573-678-8. Brewer DJ and Friedman RF (1989) Fish and Fishing in Ancient Egypt Cairo press: The American University in Cairo. ISBN 978-977-424-224-3 Cutting CL (1955) Fish saving; a history of fish processing from ancient to modern times, L. Hill. FAO and WHO (2012) Codex Alimentarius: Code of practice for fish and fishery products Rome. ISBN 978-92-5-107018-5. Gosławski, S., & Borowski, S. (2026). Valorization of Fish Waste via Anaerobic Digestion: A Systematic Literature Review and Future Research Agenda. Energies, 19(17), 4077. Hall GM (1997) Fish processing technology Springer, ISBN 978-0-7514-0273-5. Luten JB, Jacobsen C and Bekaert K (2006) Seafood research from fish to dish: quality, safety and processing of wild and farmed fish Wageningen Academic Publishers. ISBN 978-90-8686-005-0.
== Monitoring == Mold spores are always present in the environment and when conditions are favorable, mold will occur. Regular monitoring of the collection through visual inspection and environmental controls is essential to prevent an outbreak. Mold leaves a visual indication of its presence. Though mold can be any color, gray and black spots coupled with a musty odor can indicate the presence of mold. Books with these indicators can be isolated and treatment steps can be implemented. Books in the surrounding area can be monitored in case of further infestation. Presence of water or condensation and dust are other factors to look out for that can encourage mold growth. Regular cleaning and inspections will help monitor for mold growth. The control and regular monitoring of temperature and humidity levels is vital to prevent mold growth. Guidelines suggest that temperatures be maintained between 65–70 °F (18–21 °C) and relative humidity between 45%-65%. HVAC systems can be utilized and monitored to ensure these levels are maintained. Temperature and humidity values can be systematically measured and recorded to document conditions, to alert of severe fluctuations, and to indicate the functionality of the climate control systems. The systems themselves should be regularly checked for accuracy and functionality.
Psychotria viridis (Chacruna) – leaves Psychotria carthagenensis (Amyruca) – leaves Diplopterys cabrerana (Chaliponga, Chagropanga, Banisteriopsis rusbyana) – leaves Mimosa tenuiflora (M. hostilis) - root bark Other common admixtures:
== Role in phosphorylation == Phosphorylation is a biochemical process that involves the addition of phosphate to an organic compound. Steroidogenesis entails processes by which cholesterol is converted to biologically active steroid hormones. A study shows that LH via a PKA signaling pathway regulates the phosphorylation and localization of DRP1 within mitochondria of the steroidogenic cells of the ovary.
Sources: en.wikipedia.org
Most magnetic nanoparticle applications in clinical settings are used for cancer therapies. Magnetic nanoparticles have the ability to target the specific locus of the tumor, use a decreased amount of drug to treat the tumor, and result in decreased off-target effects of the drug. The most common method of introducing magnetic nanoparticles into the body is through intravenous injection; from the site of injection, the nanoparticles travel through the bloodstream. They eventually migrate to the target site with the use of external or implanted magnetic forces. A pH/magnetic field dual responsive drug loaded nanomicell was developed for targeted magnetothermal synergistic chemotherapy of cancer. In this drug delivery system, after the drug reaches the target site and tumor cell uptake is complete, an external magnetic field is applied causing a magnetothermal effect, raising the tumor cells' temperature and further promoting drug uptake. This nanocarrier system aims to improve drug stability, control drug release, and improve tumor targeting efficacy. This approach has shown increased treatment efficacy over traditional chemotherapy and has not demonstrated any noticeable biotoxicity. Cardiovascular disease treatment presents as another application of magnetic nanoparticle drug delivery. Atherosclerosis cardiovascular disease is a buildup of plaque in the inner lining of the arteries, and there are models on how magnetic nanoparticle drug delivery could be used as a treatment.
=== The Squibb Institute for Medical Research, Argentina === The Argentine government gave an exclusive license to Squibb to manufacture antibiotics in the country. To supplement the fermentation plant, Squibb constructed The Squibb Institute for Medical Research. This presented a truly unique opportunity for Ondetti, allowing him to work in one of the most advanced labs in Argentina with world-class scientists such as Dr. Deulofeu and Dr. Alfredo Sordelli. Another quirk about the Squibb laboratory was that Ondetti was not an official employee because he was a scholarship-research scientist, enabling him to focus on his thesis. Dr. Deulofeu was the head of chemistry at Squibb and his interests included alkaloid and carbohydrate chemistry. Ondetti reluctantly worked on carbohydrates for one year, after which Deulofeu offered him a job at Squibb. He refused, citing "I turned it down, because Deulofeu was an outstanding scientist, but he was very cold in the interaction with his collaborators". Realizing his mistake after one week of work at another company, he went back to Squibb and received a position there, resuming work on this thesis in 1957. Ondetti received his PhD from the University of Buenos Aires in 1960. As an employee as Squibb, Ondetti focused on alkaloid chemistry. Argentina's rich biodiversity allowed Squibb to screen many plants for unique and useful alkaloids. Any potential drug candidates were tested at The Squibb Research Institute in New Brunswick, New Jersey. The Squibb Research Institute in New Jersey was headed by Asger F.
== Public listing, financials and governance == TCI is listed on Taiwan's OTC market (stock code 8436). Regulatory and investor pages report the company's registration details, public offering timeline (public offering 25 August 2011; OTC listing 12 September 2013), paid-in capital and disclosure contacts. Quarterly and annual reports are published on the company's investor relations pages.
=== Detection in biological fluids === Clonazepam and 7-aminoclonazepam may be quantified in plasma, serum, or whole blood in order to monitor compliance in those receiving the drug therapeutically. Results from such tests can be used to confirm the diagnosis in potential poisoning victims or to assist in the forensic investigation in a case of fatal overdosage. Both the parent drug and 7-aminoclonazepam are unstable in biofluids, and therefore specimens should be preserved with sodium fluoride, stored at the lowest possible temperature and analyzed quickly to minimize losses.
Sources: en.wikipedia.org
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.
There is no single harmonised standard governing these products, and manufacturing conditions differ. Impurities may include truncated sequences, oxidation products, residual solvents, and counter-ions. Independent testing is often the only way to characterise a given lot.
Reported studies have looked at pigmentation, photoprotection, and metabolic or appetite-related endpoints in small experimental settings. Much of the evidence base is early-stage and limited in size. Questions about long-term effects and clinical relevance remain open.
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.